Samuel Aparicio
Chief Scientific Officer
Operational Management
Contextual Genomics
Canada
Biography
Dr. Aparicio graduated in medical and natural sciences from Cambridge University (UK) and clinical medicine from Oxford University (UK). He trained in internal medicine and anatomic pathology. From 2000-2005 he was a senior investigator in the Department of Oncology, Cambridge. He co-founded (1999) the UK and Singapore based biotech company Paradigm Therapeutics (now Takeda Cambridge), where he was director of science until 2004. Dr. Aparicio is currently the Nan and Lorraine Robertson Chair of Breast Cancer Research, based at UBC/BC Cancer Agency, Vancouver, Canada; and a Canada Research Chair in Molecular Oncology. His work encompasses the fields of cancer evolution, single cell genomics, mouse genetic models, high throughput screens, and translational breast cancer research.
Research Interest
Operational Management and Clinical Development
